Articles by James Calloway
GSK Expands Share Repurchases, Outlines 2026 Growth Strategy Under New CEO
GSK has acquired 650,000 shares for treasury and published its 2025 annual report, showing £32.7B in turnover. CEO Luke Miels forecasts continued profitable growth for 2026.
RELX Holds Firm on 2026 Targets Amid AI Market Jitters
RELX PLC confirmed its 2026 growth forecast on Thursday, emphasizing artificial intelligence as a core driver. The stock rose 2.74% following recent pressure linked to competitive AI concerns.
Reckitt Benckiser Stock Plunges on Margin Uncertainty Despite Strong Q4 Sales
Reckitt Benckiser's stock dropped nearly 6% as investor focus shifted from a Q4 sales beat to the lack of a 2026 profit margin target. The company flagged ongoing weakness in Europe and softer OTC demand.
BAT Hit with UK Shareholder Suit Over North Korea Sanctions
British American Tobacco is being sued in London by over 100 shareholders who allege the company did not properly disclose U.S. sanctions violations related to its North Korea operations. The legal action follows BAT's $635.2 million settlement with U.S. authorities in 2023.
Pro Medicus Rebounds 9% as Healthcare Tech Recovers from AI Selloff
Pro Medicus shares jumped over 9% on Friday, rebounding from a brutal selloff triggered by AI concerns. First-half revenue grew 28.4% to A$124.8 million, though it fell short of consensus expectations.
Malaysia Affirms Strict Lynas License Terms Despite US Minerals Pact
Malaysia's trade ministry clarified that a US critical minerals agreement does not override technical requirements for Lynas Rare Earths' operations, following the firm's 10-year license renewal. Environmental groups continue to oppose radioactive waste storage.
Westpac to Exit SEC Oversight in 2026, Maintains U.S. Debt Market Access
Westpac Banking Corp intends to terminate its SEC registration around May 2026, halting routine U.S. disclosures but preserving its ability to raise U.S. dollar funding through private debt markets.
Fortescue Directors Signal Confidence with Share Purchases Following Strong Earnings
Directors at Fortescue Ltd acquired shares worth approximately A$114,664 following the company's robust half-year results, which included a significant profit increase and a higher interim dividend.
CrowdStrike Shares Surge on Strong Long-Term Revenue Outlook
CrowdStrike Holdings saw its stock climb 4.5% following an optimistic fiscal 2027 revenue projection that exceeded analyst expectations. The cybersecurity firm reported robust quarterly growth and expanding annual recurring revenue.
Intel Under Fire From Senators Over Chinese-Linked Supplier Tests
Intel faces a bipartisan Senate inquiry over its testing of equipment from ACM Research, a firm with significant Chinese ties and clients on U.S. sanctions lists. The scrutiny comes as Intel weighs opening its advanced 18A manufacturing process to external customers.
Broadcom Surges on $100B AI Chip Forecast and $10B Buyback Plan
Broadcom shares climbed nearly 5% in extended trading following strong quarterly results and an ambitious forecast for its artificial intelligence semiconductor business, coupled with a new $10 billion stock buyback authorization.
U.S. Drafts New AI Chip Export Rules, Potentially Impacting AMD, Nvidia
U.S. officials are drafting new AI chip export regulations that could require foreign governments to invest in U.S. data centers or provide security guarantees, potentially impacting major chipmakers like AMD, Nvidia, and Intel.